Reasons, safety and efficacy analysis for conversion of HAART to TAF/FTC/BIC among HIV-infected patients
Abstract. Background:. This study aimed to determine the reasons for conversion and elucidate the safety and efficacy of transition to tenofovir alafenamide/emtricitabine/bictegravir sodium (TAF/FTC/BIC) in highly active antiretroviral therapy (HAART)-experienced HIV-infected patients in real-world...
Main Authors: | Jiang Xiao, Guiju Gao, Yi Ding, Jialu Li, Chengyu Gao, Qiuhua Xu, Liang Wu, Hongyuan Liang, Liang Ni, Fang Wang, Yujiao Duan, Di Yang, Hongxin Zhao, Yanjie Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-12-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002939 |
Similar Items
-
A retrospective observation of virologically suppressed people living with HIV by comparing switching to BIC/TAF/FTC with initial use BIC/TAF/FTC
by: Yuzhi Shi, et al.
Published: (2023-12-01) -
Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis
by: Maria Mazzitelli, et al.
Published: (2022-07-01) -
Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study
by: Filippo Lagi, et al.
Published: (2021-09-01) -
Supervised machine learning algorithms to predict the duration and risk of long-term hospitalization in HIV-infected individuals: a retrospective study
by: Jialu Li, et al.
Published: (2024-01-01) -
Torsade de pointes associated with long-term antiretroviral drugs in a patient with HIV: a case report
by: Xuechun Mu, et al.
Published: (2023-10-01)